Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-13

Clinical Trial Update: Impact of Vericiguat on Hemodynamics of Heart Failure [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the impact of vericiguat on hemodynamics in heart failure, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vericiguat (vericiguat)
  • Verquvo (vericiguat)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Heart Failure | Phase 4 | Status: ACTIVE_NOT_RECRUITING